New Regimen for Elderly Patients With mCRC

Dr. David Kerr reports on a study in which bevacizumab/capecitabine significantly improved PFS in patients at least 70 years old with advanced colorectal cancer.

Source: Medscape Oncology - January 17, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts